Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Presentation TCT India 2025

Late STEMI presenters: Role and Challenges of Interventionalist

Presenter: Michael Benz

July 26, 2025

Presentation SIF 2019

DEBATE:What is the Optimal Choice for Post PCI Patients Requiring Chronic Anticoaguation :Triple Therapy

Presenter: Michael A. Kutcher

March 29, 2019

Presentation SIF 2019

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Presenter: Michael A. Kutcher

March 28, 2019

Presentation JIM 2018

Magmaris: the impact of scaffold design and materials on lowering scaffold thrombosis

Presenter: Michael Haude

February 23, 2018

Presentation CHIP Florida 2017

Case: 50 year old white male prior history of DES stent to RCA

Presenter: Michael Yen

January 20, 2017

Presentation JIM 2016

Dreams 2G: Latest Data And Future Directions

Presenter: Michael Haude

February 09, 2016

Presentation ISET 2016

Peripheral Applications of Bioabsorbable Stents

Presenter: Michael Dake

February 07, 2016

Presentation ISET 2015

Update on Peripheral Artery Stent Surveillance: Have We Learned Anything from Clinical Trials?

Presenter: Michael R. Jaff

January 31, 2015

Presentation TCT 2014

Case #4: Swift and Safe DES for Side Branch Bail Out

Presenter: Evald H. Christiansen, George D. Dangas, Andrejs Erglis, Michael Maeng

September 14, 2014

Presentation BRS 2014

DREAMS: Unique Properties, Device Iterations and Outcomes

Presenter: Michael Haude

July 25, 2014

Presentation BRS 2014

DES Gap Analysis: Preclinical and Autopsy Observations

Presenter: Michael Joner

July 25, 2014

Presentation TCT 2013

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

Presenter: Michael Joner

October 31, 2013

Presentation TCT 2013

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

Presenter: Michael Haude

October 29, 2013

Presentation TCT 2013

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

October 29, 2013

Presentation TCT 2013

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Presenter: Michael Haude

October 27, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

The REMEDEE Trial: A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent with a PES

Presenter: Michael Haude

April 03, 2013

Presentation

BIOSOLVE-1: Safety and Performance of Drug-Eluting Absorbable Metal Scaffold (DREAMS) in Patients with De Novo Coronary Lesions

Presenter: Michael Haude

March 18, 2013

Presentation TCT 2013

Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-Rotterdam Cohort

Presenter: Giulio Stefanini, Lorenz R?ber, Michael Magro, Bindu Kalesan, Masanori Taniwaki, Cihan Simsek, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Advertisement

Late STEMI presenters: Role and Challenges of Interventionalist

DEBATE:What is the Optimal Choice for Post PCI Patients Requiring Chronic Anticoaguation :Triple Therapy

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Magmaris: the impact of scaffold design and materials on lowering scaffold thrombosis

Case: 50 year old white male prior history of DES stent to RCA

Dreams 2G: Latest Data And Future Directions

Peripheral Applications of Bioabsorbable Stents

Update on Peripheral Artery Stent Surveillance: Have We Learned Anything from Clinical Trials?

Case #4: Swift and Safe DES for Side Branch Bail Out

DREAMS: Unique Properties, Device Iterations and Outcomes

DES Gap Analysis: Preclinical and Autopsy Observations

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

The REMEDEE Trial: A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent with a PES

BIOSOLVE-1: Safety and Performance of Drug-Eluting Absorbable Metal Scaffold (DREAMS) in Patients with De Novo Coronary Lesions

Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-Rotterdam Cohort

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content